J Appl Biomed 12:277-284, 2014 | DOI: 10.1016/j.jab.2014.01.005
Avidity of anticardiolipin antibodies-A factor that could be important for their detection by ELISA methods
- Charles University in Prague and General University Hospital in Prague, First Faculty of Medicine, Institute of Medical Biochemistry and Laboratory Medicine, Kateřinská 32, 121 08 Prague 2, Czech Republic
Avidity is an important feature of antibodies associated with their pathogenic effects. Anticardiolipin antibodies (aCLs) are the most commonly examined antiphospholipid antibodies, however, their avidity has been investigated only marginally. The aim of the study was to compare the avidity of the antibodies specifically bound to the cardiolipin-coated microtitrate wells with those bound to the wells bearing no cardiolipin in various conditions. We analysed 22 serum samples with high, medium and low levels of aCL IgG. The avidity of aCL IgG was determined in serially diluted sera by the ELISA method in the presence of increasing urea concentrations (from 2 to 8 mol/L) as a chaotropic agent. The serum dilution 1:50 and 1:100 and the concentrations of urea 6 mol/L and 8 mol/L seemed to be suitable for the determination of aCL avidity. The avidity of antibodies specifically bound to the cardiolipin and those bound to the cardiolipin-free wells significantly differed in their avidity. The simultaneous determination of higher-avidity aCL and lower-avidity polyspecific antibodies, whose presence complicates the ELISA methods by an increase of the background signal, might limit the shortcomings of some ELISA methods.
Keywords: Anticardiolipin antibody; Avidity; Urea; Serum; Polyspecific antibodies
Received: November 1, 2013; Revised: January 13, 2014; Accepted: January 20, 2014; Published: November 1, 2014 Show citation
References
- Almanzar, G., Ottensmeier, B., Liese, J., et al., 2013. Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate. J. Immunol. Methods 387, 36-42.
Go to original source...
Go to PubMed...
- Cucnik, S., Bozic, B., Kveder, T., et al., 2005. Avidity of antibeta2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome. Ann. N.Y. Acad. Sci. 1051, 141-147.
Go to original source...
Go to PubMed...
- Cucnik, S., Kveder, T., Ulcova-Gallova, Z., et al., 2011. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies. Lupus 20, 1166-1171.
Go to original source...
Go to PubMed...
- Cucnik, S., Kveder, T., Artenjak, A., et al., 2012. Avidity of antibeta2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Lupus 21, 764-765.
Go to original source...
Go to PubMed...
- Dauner, J.G., Pan, Y., Hildesheim, A., et al., 2012. Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals. Mol. Cell. Probes 26, 73-80.
Go to original source...
Go to PubMed...
- de Laat, B., Derksen, R.H., de Groot, P.G., 2006. High-avidity antibeta glycoprotein I antibodies highly correlate with thrombosis in contrast to low-avidity anti-beta glycoprotein I antibodies. J. Thromb. Haemost. 4, 1619-1621.
Go to original source...
Go to PubMed...
- Dimitrov, J.D., Lacroix-Desmazes, S., Kaveri, S.V., et al., 2008. Insight into the mechanism of the acquired antibody autoreactivity. Autoimmun. Rev. 7, 410-414.
Go to original source...
Go to PubMed...
- Dimitrov, J.D., Lacroix-Desmazes, S., Kaveri, S.V., 2011. Important parameters for evaluation of antibody avidity by immunosorbent assay. Anal. Biochem. 418, 149-151.
Go to original source...
Go to PubMed...
- Fialova, L., Bartos, A., Svarcova, J., et al., 2011. Increased intrathecal high-avidity anti-tau antibodies in patients with multiple sclerosis. PLoS ONE 6, e27476.
Go to original source...
Go to PubMed...
- Fialova, L., Svarcova, J., Bartos, A., et al., 2012. Avidity of antineurocytoskeletal antibodies in cerebrospinal fluid and serum. Folia Microbiol. (Praha) 57, 415-419.
Go to original source...
Go to PubMed...
- Flori, P., Tardy, L., Patural, H., et al., 2004. Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women. Clin. Diagn. Lab. Immunol. 11, 669-674.
Go to original source...
Go to PubMed...
- Gharavi, A., Reiber, H., 1996. Affinity and avidity of autoantibodies. In: Peter, J., Shoenfeld, Y. (Eds.), Autoantibodies. Elsevier, Amsterdam, pp. 13-23.
Go to original source...
- Lakos, G., Favaloro, E.J., Harris, E.N., et al., 2012. International consensus guidelines on anticardiolipin and anti-beta2glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum. 64, 1-10.
Go to original source...
Go to PubMed...
- Liaskos, C., Rigopoulou, E., Zachou, K., et al., 2005. Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. J. Autoimmun. 24, 251-260.
Go to original source...
Go to PubMed...
- Manfredini, E., Nobile-Orazio, E., Allaria, S., et al., 1995. Anti-alpha- and beta-tubulin IgM antibodies in dysimmune neuropathies. J. Neurol. Sci. 133, 79-84.
Go to original source...
Go to PubMed...
- Matheus, S., Deparis, X., Labeau, B., et al., 2005. Use of four dengue virus antigens for determination of dengue immune status by enzyme-linked immunosorbent assay of immunoglobulin G avidity. J. Clin. Microbiol. 43, 5784-5786.
Go to original source...
Go to PubMed...
- Miyakis, S., Lockshin, M.D., Atsumi, T., et al., 2006. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4, 295-306.
Go to original source...
Go to PubMed...
- Notkins, A.L., 2004. Polyreactivity of antibody molecules. Trends Immunol. 25, 174-179.
Go to original source...
Go to PubMed...
- Pellegrino, N.M., Caccavo, D., 2007. Variability in anticardiolipin antibody detection: role of nonspecific IgG binding and different microtiter plates. Clin. Appl. Thromb. Hemost. 13, 404-409.
Go to original source...
Go to PubMed...
- Pengo, V., Denas, G., Banzato, A., et al., 2012. Interpretation of laboratory data and need for reference laboratories. Lupus 21, 732-733.
Go to original source...
Go to PubMed...
- Pierangeli, S.S., Harris, E.N., 2008. A protocol for determination of anticardiolipin antibodies by ELISA. Nat. Protoc. 3, 840-848.
Go to original source...
Go to PubMed...
- Pohanka, M., 2009. Monoclonal and polyclonal antibodies production-preparation of potent biorecognition element. J. Appl. Biomed. 7, 115-121.
Go to original source...
- Pullen, G.R., Fitzgerald, M.G., Hosking, C.S., 1986. Antibody avidity determination by ELISA using thiocyanate elution. J. Immunol. Methods 86, 83-87.
Go to original source...
Go to PubMed...
- Roggenbuck, D., Egerer, K., von Landenberg, P., et al., 2012. Antiphospholipid antibody profiling: time for a new technical approach? Autoimmun. Rev. 11, 821-826.
Go to original source...
Go to PubMed...
- Rupin, A., Gruel, Y., Watier, H., et al., 1991. ELISA for the detection of anticardiolipin antibodies. High specificity based on the use of adult bovine serum as buffer and systematic subtraction of non-specific binding. J. Immunol. Methods 138, 225-231.
Go to original source...
Go to PubMed...
- Steward, M.W., Reinhardt, M.C., Staines, N.A., 1979. The genetic control of antibody affinity. Evidence from breeding studies with mice selectively bred for either high or low affinity antibody production. Immunology 37, 697-703.
Go to PubMed...
- Szabo, P., Mujalli, D.M., Rotondi, M.L., et al., 2010. Measurement of anti-beta amyloid antibodies in human blood. J. Neuroimmunol. 227, 167-174.
Go to original source...
Go to PubMed...
- Vlachoyiannopoulos, P.G., Petrovas, C., Tektonidou, M., et al., 1998. Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis. J. Clin. Immunol. 18, 380-391.
Go to original source...
Go to PubMed...
- Wong, R., Favaloro, E., Pollock, W., et al., 2004. A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays. Pathology 36, 182-192.
Go to original source...
Go to PubMed...
- Xiao, Y., Isaacs, S.N., 2012. Enzyme-linked immunosorbent assay (ELISA) and blocking with bovine serum albumin (BSA)-not all BSAs are alike. J. Immunol. Methods 384, 148-151.
Go to original source...
Go to PubMed...
- Zachou, K., Liaskos, C., Rigopoulou, E., et al., 2006. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin. Immunol. 119, 203-212.
Go to original source...
Go to PubMed...